Centrum Medyczne Kermed

Bydgoszcz 85-231

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Atrial Fibrillation, Cardiovascular Disease, High Cardiovascular Risk, Obesity, Overweight, Paroxysmal Supraventricular Tachycardia, Prevention of Stroke or Systemic Embolism, Type 2 Diabetes

Studies at this site

• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed